Neurobiology of Disease

Article	Citations
Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism	229
The neoliberal leaning of the neuroscience discourse when it deals with mental health and learning disorders	164
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition	135
Postnatal Foxp2 regulates early psychiatric-like phenotypes and associated molecular alterations in the R6/1 transgenic mouse model of Huntington's disease	128
Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression	113
Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal data	111
The predictive value of mBDNF for major adverse cardiovascular events in stable coronary artery disease patients with depressive symptoms: A single-center, 5-year follow-up study	111
MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers	101
Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis	99
Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner	98
Editorial Board	98
Serotonin innervation of the subthalamic nucleus in parkinsonian monkeys	95
Estrogen-related receptor gamma is a regulator of mitochondrial, autophagy, and immediate-early gene programs in spiny projection neurons: Relevance for transcriptional changes in Huntington disease	91
Activating the vlPAG-LC neural pathway alleviates neuropathic pain and comorbid anxiety-like behaviors through distinct projections	88
Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs	84
CCR5 deficiency normalizes TIMP levels, working memory, and gamma oscillation power in APOE4 targeted replacement mice	81
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain	81
Temporal modulation of microglial repopulation attenuates retinal degeneration in retinitis pigmentosa	80
Stem cell therapy for central nervous system disorders: Metabolic interactions between transplanted cells and local microenvironments	79
New perspectives on the role of biological factors in anorexia nervosa: Brain volume reduction or oxidative stress, which came first?	75
4-Aminopyridine induced hyperpolarizing oscillations in pediatric human epileptic tissue are network-driven potassium currents that are abolished by activation of KCNQ2–5 (Kv7.2-Kv7.5) channels	75
Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours	75
Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics	73
The altered sensitivity of acute stress induced anxiety-related behaviors by modulating insular cortex-paraventricular thalamus-bed nucleus of the stria terminalis neural circuit	73
Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy	70

Gut-brain axis in the pathogenesis of sepsis-associated encephalopathy	66
Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration	64
Alterations in beta oscillatory activity occur with the emergence of parkinsonian motor signs across the basal ganglia-thalamocortical network	62
Intermittent fasting produces antidepressant-like effects by modulating dopamine D1 receptors in the medial prefrontal cortex	62
Metabolic reprogramming of glial cells: Fatty acid pathways as regulators of remyelination in multiple sclerosis	61
Amyloid beta peptides (Aβ) from Alzheimer's disease neuronal secretome induce endothelial activation in a human cerebral microvessel model	60
Identification of an epilepsy-linked gut microbiota signature in a pediatric rat model of acquired epilepsy	60
Cerebellar GABA and executive function among adult female carriers of the fragile X messenger ribonucleoprotein 1 premutation: a pilot study to examine neural underpinnings of the clinical phenotype	60
Potential clinical and biochemical markers for the prediction of drug-resistant epilepsy: A literature review	57
T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease	57
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity	57
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a mice	56
Cerebrospinal amino acid profiling in a large cohort of neuropediatric patients with epilepsy	55
Early suppression of excitability in subcortical band heterotopia modifies epileptogenesis in rats	55
A novel mouse model of chronic neuronopathic Gaucher disease exhibits Parkinson's disease-like phenotypes	55
Tissue-specific immune and MAPK signatures in models of reduced Progranulin and Western diet	54
Direct conversion of human umbilical cord mesenchymal stem cells into dopaminergic neurons for Parkinson's disease treatment	53
Reducing the lipase LIPE in mutant α-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism	52
APP as an innate injury-response molecule	52
Cogwheel rigidity in Parkinson's disease: Clinical, biomechanical and neurophysiological features	52
B cell depletion modulates glial responses and enhances blood vessel integrity in a model of multiple sclerosis	50
Kainate receptors modulate the microstructure of synchrony during dentate gyrus epileptiform activity	48
Corrigendum to “Isoflurane on brain inflammation” [Neurobiology of Disease, 62 (2014) Pages 365–371]	48
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease	48
Corrigendum to “Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy” [Neurobiology	48
Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21	47
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models	47
Influence of WWOX/MAF genes on cognitive performance in patients with Parkinson's disease	47
Altered static and dynamic functional connectivity of the default mode network across epilepsy subtypes in children: A resting-state fMRI study	47
Epigenomic analysis of Alzheimer's disease brains reveals diminished CTCF binding on genes involved in synaptic organization	46
General loss of proteostasis links Huntington disease to Cockayne syndrome	46
Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease	46
Neuronal MeCP2 in the dentate gyrus regulates mossy fiber sprouting of mice with temporal lobe epilepsy	46
Diffusion along perivascular spaces as a marker for Glymphatic system impairment in spinocerebellar Ataxia type 3	45
Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome	45
Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium	45
Structural and functional abnormalities in thalamic neurons following neocortical focal status epilepticus	44
Hippocampal seizures differentially modulate locus coeruleus activity and result in consistent time-locked release of noradrenaline in rat hippocampus	44
Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model	43
The extracellular matrix as a dynamic regulator of brain function and plasticity	43
Linking subjective cognitive decline to glymphatic dysfunction in Parkinson's disease	43
GD3 synthase deficiency disrupts Na+/K+-ATPase and plasma membrane Ca2+-ATPase function in mouse brain	43
Hippocampal APOE/S1P axis regulates synaptic and behavioral deficits in a mouse model of autism	42
Multimodal imaging of glymphatic dysfunction and retinal vascular changes as biomarkers for Alzheimer's disease	42
Cortical network resilience to transient anoxia involves redistribution of single-neuron firing	42
Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease	42
Analysis of mitochondrial DNA heteroplasmy in sporadic ALS suggests technical limitations rather than disease association	42
Sunitinib-mediated inhibition of STAT3 in skeletal muscle and spinal cord does not affect the disease in a mouse model of ALS	41
Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids	41
Rhythms in barriers and fluids: Circadian clock regulation in the aging neurovascular unit	41

Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model	41
Ischemic brain edema: Emerging cellular mechanisms and therapeutic approaches	39
Elucidating cortical neurovascular involvement in Huntington's disease using human brain tissue microarrays	39
Exo-miR-144-3p as a promising diagnostic biomarker for depressive symptoms in heart failure	39
Machado Joseph disease severity is linked with gut microbiota alterations in transgenic mice	38
Gene-environment interaction elicits dystonia-like features and impaired translational regulation in a DYT-TOR1A mouse model	37
Sphingolipid metabolism and signaling in the central nervous system: Effects on brain health	37
Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models	37
Disease-associated mutations in C-terminus of HSP70 interacting protein (CHIP) impair its ability to negatively regulate mitophagy	37
From molecular convergence to clinical divergence: Comparative pathogenic mechanisms and therapeutic trajectories in C9orf72-ALS/FTD and myotonic dystrophy	37
Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons	37
Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease	37
Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way	36
Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias	36
Corrigendum to “Rhythms in barriers and fluids: Circadian clock regulation in the aging neurovascular unit” [Neurobiology of Disease, Volume 181 (1st June 2023) Article Number 106120]	35
Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model	35
Unveiling the hidden genetic conundrum linking pulmonary diseases and neuropsychiatric disorders: Novel insights from advanced omics-based analyses of the lung-brain axis	34
Modulation of miR-145 in a mouse model of multiple sclerosis: A promising approach to attenuate inflammation and degeneration	34
Microstructural changes in the caudate nucleus and hippocampus and their association with cognitive function in cerebral small vessel disease: A quantitative susceptibility mapping study	34
Spatiotemporal dynamics of 5-HT6 receptor ciliary localization during mouse brain development	34
Delta oscillation coupled propagating fast ripples precede epileptiform discharges in patients with focal epilepsy	34
Overexpression of Bmp4 induces microphthalmia by disrupting embryonic neural retina	34
Retraction Notice to “Anti-neutrophil antibody enhances the neuroprotective effects of G-CSF by decreasing number of neutrophils in hypoxic ischemic neonatal rat model” [Neurobiology of Disease 69 (20	34
Charting the shared genetic architecture of Alzheimer's disease, cognition, and educational attainment, and associations with brain development	34
Early social deficits in TgF344-AD rats are accompanied by sex-specific parvalbumin-positive interneuron reduction and altered brain oscillations in the hippocampal CA2	34
Causal relationship of gut microbiota and metabolites on cognitive performance: A mendelian randomization analysis	33
Oligodendrocyte myelin glycoprotein impairs dendritic arbors via schizophrenia risk gene Trio	33
Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease	33
Frequency-coded spatiotemporal control of telencephalic ictal oscillations and inter-cortical coherence by thalamus	33
Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer’s disease	33
Inhibitory circuit dysfunction as a potential contributor to cortical reorganization in Glioblastoma progression	33
Activin A targets extrasynaptic NMDA receptors to ameliorate neuronal and behavioral deficits in a mouse model of Huntington disease	32
RhoA deletion in macrophages/microglia aggravates blood-brain barrier disruption after ischemic stroke reperfusion injury by promoting endothelial cell apoptosis and pyroptosis	32
Rethinking the cilia hypothesis of hydrocephalus	32
Multiple sclerosis lesions exhibit sex-specific steroid changes	32
BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease	32
NOTCH3 R545C mutation drives vascular-neuronal dysfunction and cognitive impairment in CADASIL pathogenesis	32
MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology	32
Environmental stimulation in Huntington disease patients and animal models	32
Brain somatic mosaicism in epilepsy: Bringing results back to the clinic	32
Differential profiles of serum cytokines in Parkinson's disease according to disease duration	32
Conservation of strain properties of bank vole-adapted chronic wasting disease in the absence of glycosylation and membrane anchoring	32
Retraction Notice to “Hypercholesterolemia-induced A<beta> accumulation in rabbit brain is associated with alteration in IGF-1 signaling” [Neurobiology of Disease 32 (2008) 426–432]	32
Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation	32
The hypothalamic vasopressin circuit drives lateralized endocrine signaling	32
Impaired learning and memory generated by hyperthyroidism is rescued by restoration of AMPA and NMDA receptors function	32
Editorial Board	31
The LRRK2-G2019S mutation attenuates repair of brain injury partially by reducing the release of osteopontin-containing monocytic exosome-like vesicles	31
Editorial Board	31
Inhibition of PTPRS function does not affect the survival or regeneration of dopaminergic neurons but alters synaptic function in the nigrostriatal pathway	31
Editorial Board	31
Corrigendum to “Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of cuprizone-treated mouse brain” [Neurobiology of Disease 176 (2023); 105961. doi: 10.1	31
Impaired motor unit recovery and maintenance in a knock-in mouse model of ALS-associated Kif5a variant	30
Small molecule ion channel agonist/antagonist screen reveals seizure suppression via glial Irk2 activation in a Drosophila model of Dup15q syndrome	30
Deep learning combining FDG-PET and neurocognitive data accurately predicts MCI conversion to Alzheimer's dementia 3-year post MCI diagnosis	30
Phenotypic analysis of multielectrode array EEG biomarkers in developing and adult male Fmr1 KO mice	30
Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy	30
Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia	30
Combined deletion of Mct8 and Dio2 impairs SVZ neurogliogenesis and olfactory function in adult mice	30
Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models	30
Mild hypothermia fails to protect infant macaques from brain injury caused by prolonged exposure to Antiseizure drugs	30
A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI	29
Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis	29
Immune regulation in neurovascular units after traumatic brain injury	29
Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis models	29
P2X7 receptor of olfactory bulb microglia plays a pathogenic role in stress-related depression in mice with allergic rhinitis	29
Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate	29
Structural interhemispheric connectivity defects in mouse models of BBSOAS: Insights from high spatial resolution 3D white matter tractography	29
Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ	28
Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier	28
Loss of mitochondrial enzyme GPT2 causes early neurodegeneration in locus coeruleus	28
Endothelial pyroptosis-driven microglial activation in choroid plexus mediates neuronal apoptosis in hemorrhagic stroke rats	27
Subthalamic and pallidal oscillations and their couplings reflect dystonia severity and improvements by deep brain stimulation	27
Astrocyte heterogeneity in ischemic stroke: Molecular mechanisms and therapeutic targets	27
The Warburg micro syndrome protein RAB3GAP1 modulates neuronal morphogenesis and interacts with axon elongation end ER-Golgi trafficking factors	27
Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities	27
Combination of CSF α-synuclein seed amplification assay and amyloid-β42 predicts cognitive decline in Parkinson's disease	27
Bioenergetic and protein processing imbalances in iPSC-dopamine neurons from individuals with idiopathic Parkinson's disease	27
Considering Big tau as a novel and specific biomarker for spinal motor neuron pathology	27
The impact of insulin resistance on cognitive impairment and cerebrospinal fluid biomarkers in Alzheimer's disease	27

Single nucleus RNA sequencing unveils relationship between microglia and endothelial cells in mixed Alzheimer's disease and vascular pathology	27
Altered retinal structure and function in Spinocerebellar ataxia type 3	26
FTD-associated mutations in Tau result in a combination of dominant and recessive phenotypes	26
Editorial to the special issue: “The neurobiology of synaptic dysfunction in brain disorders”	26
Impairment in the homeostatic recruitment of layer 5/6 neurons following whisker stimulation in Fmr1 KO mice	26
Multi-omics characterization of oncosis in spinal cord injury	26
Ultra-high-field (9.4 T) ex vivo diffusion MRI tractography reveals microstructural differences in Parkinson's disease motor subtypes	26
Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease	26
Astrocytic α7-nicotinic acetylcholine receptors mediate pain information processing and perception	26
What do we know and don't know about the brain barrier in health and disease?	26
A neural circuit from paratenial thalamic nucleus to anterior cingulate cortex for the regulation of opioid-induced hyperalgesia in male rats	26
Editorial Board	26
Pathological gain-of-function human variants in the GRIK2 kainate receptor gene cause wide-ranging behavioral dysfunction and seizures in mouse models	26
Technological and computational approaches to detect somatic mosaicism in epilepsy	26
Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study	26
Editorial Board	26
Sex differences of synaptic plasticity and microglial remodeling in the dorsal hippocampus following trigeminal nerve injury in mice	26
Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons	26
Mu-opioid receptor activation in the habenula modulates synaptic transmission and depression-like behaviors	25
BDNF/TrkB pathway activation in D1 receptor-expressing striatal projection neurons plays a protective role against L-DOPA-induced dyskinesia	25
Alpha-synuclein modulates the repair of genomic DNA double-strand breaks in a DNA-PKcs-regulated manner	25
An NTS-CeA projection modulates depression-like behaviors in a mouse model of chronic pain	25
Wirelessly transmitted subthalamic nucleus signals decode endogenous pain levels in Parkinson's disease patients	25
Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease	25
Early developmental alterations of CA1 pyramidal cells in Dravet syndrome	25
Loss of oxytocin receptors in hilar mossy cells impairs social discrimination	25
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis	25
N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease	25
Defective anterograde protein-trafficking contributes to endoplasmic reticulum-stress in a CLN1 disease model	25
Nigrostriatal tract defects in mice with aromatic l-amino acid decarboxylase deficiency	25
Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesia	25
The Drosophila blood-brain barrier emerges as a model for understanding human brain diseases	24
Alzheimer's disease risk ABCA7 p.A696S variant disturbs the microglial response to amyloid pathology in mice	24
Early neural dysfunction reflected in degraded auditory cortex responses in pre-regression heterozygous Mecp2 rats	24
Hippocampal neural circuit connectivity alterations in an Alzheimer's disease mouse model revealed by monosynaptic rabies virus tracing	24
Epileptic-network-based prediction and control of seizures in humans	24
Pridopidine rescues BDNF/TrkB trafficking dynamics and synapse homeostasis in a Huntington disease brain-on-a-chip model	24
Role of lipocalin 2 in stroke	24
Imbalanced mitochondrial dynamics in human PD and α-synuclein mouse brains	24
The downregulation of Kv1 channels in Lgi1−/− mice is accompanied by a profound modification of its interactome and a parallel decrease in Kv2 channels	24
Unraveling Parkinson's disease motor subtypes: A deep learning approach based on spatiotemporal dynamics of EEG microstates	24
Increased level of exosomal miR-20b-5p derived from hypothermia-treated microglia promotes neurite outgrowth and synapse recovery after traumatic brain injury	24
Exposure to environmental airborne particulate matter caused wide-ranged transcriptional changes and accelerated Alzheimer's-related pathology: A mouse study	24
Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease	24
Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease	23
Apolipoproteins in ischemic stroke progression and recovery: Key molecular mechanisms and therapeutic potential	23
Editorial Board	23
Remodeling of the brain angioarchitecture in experimental chronic neurodegeneration	23
Exploring the dynamic pathogenesis of Parkinson's disease by case-control and longitudinal blood transcriptome analyses	23
Thrombospondin-1 regulates synaptic transmission in hippocampal field CA2 and social behavior in mice	23
Altered thalamocortical tract trajectory growth with undisrupted thalamic parcellation pattern in human lissencephaly brain at mid-gestational stage	23
Decoding the neurocircuitry of gut feelings: Region-specific microbiome-mediated brain alterations	23
Comprehensive characterization and validation of the Prp-hPFN1G118V mouse model: Guidelines for preclinical therapeutic testing for ALS	23
Delayed postnatal brain development and ontogenesis of behavior and cognition in a mouse model of intellectual disability	23
Editorial: The gut microbiome and epilepsy	23
Dual role of microglia in neuroinflammation and neurodegenerative diseases	23
Cognitive trajectories in early Parkinson's disease: A multimodal MRI study of brain structure and cognitive decline	23
Editorial Board	23
FMRP attenuates Tau pathology through the CDK5/p35 signaling pathway	23
Corrigendum to “Oxidative stress activates the c-Abl/p73 proapoptotic pathway in Niemann-Pick type C neurons” [Neurobiology of Disease Volume 41, Issue 1, January 2011, Pages 209–218]	22
Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice	22
A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity	22
PTEN deletion in the adult dentate gyrus induces epilepsy	22
Microglial phagoptosis in development, health, and disease	22
People with HIV exhibit spectrally distinct patterns of rhythmic cortical activity serving cognitive flexibility	22
Astrocyte-microglia crosstalk in the hippocampus mediates cognitive impairments induced by chronic intermittent hypoxia	22
Multi-omics analysis identifies mitochondrial dysfunction in CD83+ macrophages as a key event in diabetic peripheral neuropathy progression	22
Aberrant dynamic functional network connectivity in progressive supranuclear palsy	22
NKCC1 inhibition reduces periaxonal swelling, increases white matter sparing, and improves neurological recovery after contusive SCI	21
SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients	21
Stress granules in the spinal muscular atrophy and amyotrophic lateral sclerosis: The correlation and promising therapy	21
Neuroimmune signaling mediates astrocytic nucleocytoplasmic disruptions and stress granule formation associated with TDP-43 pathology	21
Altered APP trafficking drives amyloidogenic processing in primary neurons from the AppNL-F knock-in mouse model of Alzheimer's disease	21
Phosphorylated-tau associates with HSV-1 chromatin and correlates with nuclear speckles decondensation in low-density host chromatin regions	21
Reactive astrocytes associated with prion disease impair the blood brain barrier	21
The contribution of spinal dorsal horn astrocytes in neuropathic pain at the early stage of EAE	21
GluN2D-containing NMDA receptors in parvalbumin neurons in the nucleus accumbens regulate nocifensive responses in neuropathic pain	21
Globular-shaped Aβ oligomers have diverse mechanisms for promoting Aβ aggregations with the facilitation of fibril elongation	21
Retraction notice to ‘Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats’ [Neurobiology of Disease 110 (2018) 59–67]	21
Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology	21
Microcephaly with a disproportionate hippocampal reduction, stem cell loss and neuronal lipid droplet symptoms in Trappc9 KO mice	21
Fatty acid binding proteins and their involvement in anxiety and mood disorders	21
PYK2 in the dorsal striatum of Huntington's disease R6/2 mouse model	20
A role for the autophagy receptor NBR1 in the degradation of tau aggregates	20
Exploring the heterogeneous transcriptional response of the CNS to systemic LPS and Poly(I:C)	20
Tsc1 deletion in Purkinje neurons disrupts the axon initial segment, impairing excitability and cerebellar function	20
Increased oxytocin/vasopressin ratio in bipolar disorder in a cohort of human postmortem adults	20
Resting-state EEG signatures of Alzheimer's disease are driven by periodic but not aperiodic changes	20
Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies	20
Neuron-astrocyte transmitophagy is altered in Alzheimer's disease	20
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study	20
Endoplasmic reticulum stress: The underlying mechanism of chronic pain	20
The relationship between anaemia, haemoglobin levels, and cognitive function: Evidence in two population-based cohorts from India and the United States	20
Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation	19
Editorial Board	19